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Abstract
Background: Individual differences between human embryonic stem cell (hESC) lines are poorly
understood. Here, we describe the derivation of five hESC lines (called FES 21, 22, 29, 30 and 61)
from frozen-thawed human embryos and compare their individual differentiation characteristic.
Results: The cell lines were cultured either on human or mouse feeder cells. The cells grew
significantly faster and could be passaged enzymatically only on mouse feeders. However, this was
found to lead to chromosomal instability after prolonged culture. All hESC lines expressed the
established markers of pluripotent cells as well as several primordial germ cell (PGC) marker genes
in a uniform manner. However, the cell lines showed distinct features in their spontaneous
differentiation patterns. The embryoid body (EB) formation frequency of FES 30 cell line was
significantly lower than that of other lines and cells within the EBs differentiated less readily.
Likewise, teratomas derived from FES 30 cells were constantly cystic and showed only minor solid
tissue formation with a monotonous differentiation pattern as compared with the other lines.
Conclusion: hESC lines may differ substantially in their differentiation properties although they
appear similar in the undifferentiated state.
Background
Embryonic stem (ES) cells are pluripotent cells derived
from the inner cell mass (ICM) of the mammalian blasto-
cyst. They have the potential to differentiate, both in vitro
and in vivo, into derivatives of all three embryonic germ
cell layers. According to current understanding, ES cells
can be maintained in an undifferentiated stage indefi-
nitely in adequate culture conditions [1].
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The first human ES cell (hESC) lines were isolated in 1998
raising hopes for hESC derived cell replacement therapies
for various degenerative diseases [2]. As the ES cell lines
are derived from individual embryos, they are likely to
have unique characteristics. Recent studies focusing on
epigenetic of different hESC lines have indeed indicated
that individual cell lines may have distinct line specific
epigenetic profiles [3,4] which may affect their differenti-
ation properties. Adaptation to distinct cell culture condi-
tions may cause selection pressure altering the features of
the cell lines at the epigenetic or chromosomal level.
While there are plenty of studies regarding differentiation
of hESC into a variety of cell types, only a few studies
address the differences between individual cell lines and
they are mainly focused on transcriptional profiling.
Although these studies have indicated that the mRNA
expression patterns do vary to some extent between the
hESC lines, biological significance of the variation has not
been studied in detail [5-9].
Undifferentiated ES cells are characterized by a distinct
morphology and by the expression of molecular markers
typical for mammalian pluripotent cells. The most com-
monly used cell surface markers on hESC are the glycoli-
pid antigens SSEA-3 and SSEA-4 and the keratan sulphate
proteoglygans Tra 1–60 and Tra 1–81. They are also
expressed in the ICM cells of human blastocysts as well as
in pluripotent human embryonic carcinoma cells [10-12].
In addition to the surface markers, the expression of cer-
tain transcription factors is a hallmark of ES cells. OCT-4
(POU-domain class-5 transcription factor, POU5f1) is the
best known and most widely used. It is expressed in the
ICM of the blastocyst stage embryo and becomes down-
regulated upon differentiation [13,14]. Later, a homeo-
protein named Nanog was found to be present exclusively
in undifferentiated ES cells [15] and also shown to be cru-
cial for the formation of pluripotent ICM cells in mouse
[16]. Recent studies have indicated that genes involved in
the early commitment of primordial germ cells (PGC) are
expressed in undifferentiated hESCs as well [17]. Indeed,
it has been postulated that the closest in vivo equivalents
of the ES cells might be the early committed PGCs rather
than primitive ectoderm cells [18,19].
In this report, we describe the derivation of five hESC lines
from frozen-thawed human embryos. A universal tran-
scriptional comparison of these lines has been reported
earlier [9]in vitro . We now report of the variable differen-
tiation characteristics between individual lines and of the
expression of PGC associated genes in undifferentiated
and differentiated cells.
Results
Derivation and culture of the hESC lines
Out of 323 frozen-thawed zygotes, 83 (26%) formed blas-
tocysts. Of the 83 blastocysts, 70 ICMs were successfully
isolated onto human foreskin fibroblast (HFF) or mouse
embryonic fibroblast (MEF) feeder cells. Five (7%) iso-
lated ICMs formed continuously growing hESC lines. Two
of the hESC lines (FES 21 and FES 22) were initially estab-
lished on MEF and three (FES 29, FES 30 and 61) on HFF
feeder cells. Later all the cell lines were characterized on
both feeder types. The gene expression and teratoma anal-
ysis was performed with hESCs cultured on HFFs, embry-
oid body (EB) formation analyses with hESC cultured on
MEF.
The morphology of the hESC colonies didn't vary remark-
ably between the two feeder systems, if the cells were pas-
saged mechanically. However, the density of the colonies
within single dishes was clearly higher in MEF cultures
than in cultures grown on HFF feeders. Notably, new
hESC colonies appeared to start to grow from smaller
pieces of passaged colonies on MEF than on HFF (Figure
1). While cell clusters with 20–30 cells frequently attached
on MEF feeders and start to grow as undifferentiated colo-
nies more than 100 cells/cluster appeared to be needed to
initiate normal undifferentiated growth on HFF feeders.
Morphology of hESC colonies Figure 1
Morphology of hESC colonies. Cells grown on MEF (A 
and C) or HFF (B and D) after enzymatic passaging with col-
lagenase IV. The initially attached colonies are smaller on 
MEF (A and B, FES 22 cells 36 h after passaging). At three 
days, the colonies on MEF (C) are larger, better defined and 
more homogenous than on HFF (D). Scale bar is 100 μm.BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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Furthermore, the small hESC clusters attached on HFF
feeders differentiated more easily than on MEF feeders.
We also analyzed the population doubling time of the
cells in both culture systems. The average growth rate of
FES 22 cells was approximately 1.5 times higher (popula-
tion doubling time 24 vs. 36 h) when cultured on MEF as
compared to HFF (Figure 2). The hESC lines were initially
passaged mechanically by splitting colonies in up to 5
clusters (each containing 300–400 cells) and transferring
pieces on new dishes. In order to more effectively expand
the cell mass, enzymatic passaging with collagenase was
introduced. Although both feeder types maintained the
pluripotency of the hESC lines, HFF did not support long
term enzymatic passaging in our hands. Eventually
(within 5–10 passages) the cells lost their pluripotency
and differentiated into various lineages. Four cell lines
retained a normal male karyotype 46, XY and one (FES
30) a normal female karyotype 46, XX as long as the cells
were cultured on human feeders. However, after about 40
passages on mouse feeders with enzymatic passaging,
abnormal karyotypes were found in two lines. The karyo-
type of FES 22 cells was transformed into 48, XY, +12, +17
and that of FES 30 cells into 47, XX, +20 (Figure 3).
The expression of hESC markers
All the FES lines expressed OCT-4 and NANOG as detected
by RT-PCR. The cells were also positive for the hESC asso-
ciated epitopes TRA 1–60, TRA 1–81 and SSEA-4 as
detected by immunohistochemistry (IHC) or flow cytom-
etry and had strong alkaline phosphatase activity (not
shown).
We next identified the mRNA expression of various germ
cell associated genes known or suspected to have roles in
preventing the differentiation of primordial germ cells in
other organisms or whose expression has previously been
found to be restricted to germ cells. Their specificity for
undifferentiated FES 22, 29 and 30 cells was evaluated by
comparing their expression levels in undifferentiated
hESCs, EBs and stage 3 (ST 3) differentiated cells (Figure
4). All the studied germ cell associated genes DAZL,
PUM2, STELLAR, PIWIL2 and TEX-14 as well as OCT-4,
NANOG  and  FGF-4, genes that have been previously
described to play essential roles in the regulation of hESC
pluripotency, were detected in the lines analyzed. They
were also expressed in EBs, indicating either presence of a
substantial amount of undifferentiated cells in EBs or that
the expression of these genes is not strictly restricted to
pluripotent hESCs. The more fully differentiated stage 3
cells (a mix of four cell lines) showed weak expression of
PUM2  and  TEX-14  transcripts, while OCT-4,  NANOG,
FGF4, DAZL, STELLAR and PIWIL2 were all undetectable
at this stage.
Karyotype analysis Figure 3
Karyotype analysis. Abnormal karyotypes of two FES lines. 
FES 22 (48, XY, +12, +17; A) and FES 30 (47, XX, +20; B) 
cells after prolonged enzymatic passaging on MEF.
Effect of feeders on cell proliferation Figure 2
Effect of feeders on cell proliferation. Analysis of popu-
lation doubling time on different types of feeders. Daily cell 
counts of triplicate wells of FES 22 cells are shown (mean ± 
SD).BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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Embryoid body formation
The spontaneous differentiation capacity of the FES cell
lines was evaluated both in vitro and in vivo. All the cell
lines formed EBs with typical cystic morphology. The EBs
contained cells expressing markers of all three germ cell
layer derivatives (Figure 5A–D; staining shown for FES
29).
Interestingly, clear cell-line dependent variation in EB for-
mation was reproducibly detected. The FES 30 cell line
formed fewer EBs as compared to FES 22 and 29 lines (37
vs. 51 and 50 EBs per 50 colonies after 7 days, respec-
tively) (Figure 6). We next analyzed the expression of var-
ious differentiation markers after EB formation by IHC.
The total area of OCT-4 positive cells counted from two
independent sections of approximately 50–60 EBs was
clearly larger in FES 30 derived EBs (approximately 80%)
than in those derived from FES 22 or 29 lines (less than
7% and about 20%, respectively, Figure 7A–B) indicating
significant difference in the loss of pluripotent cells
between the analyzed hESC lines. On the other hand,
there was practically no expression of the mesodermal
marker Brachyury in FES 30, while it was readily detecta-
ble in FES 22 and 29 derived EBs (Figure 7C–D). Simi-
larly, FES 30 EBs showed minimal expression of
endodermal HNF3β protein while the corresponding
expression levels were 6–50 fold higher in EBs derived
from FES 29 and FES 22 (0.08% of total section area vs.
0.5% and 4%, data not shown)). Altogether, the results
show that in the given EB assay, FES 30 cells differentiate
less readily than do FES 22 and 29 cells.
Teratoma formation
To study the in vivo differentiation potential, cells from all
FES lines were transplanted into nude mouse testis. Again,
the differentiation patterns of the teratomas showed clear
line specific features. FES 30-derived teratomas always
consisted of more cystic components with a smaller solid
tumor mass as compared with the other lines (FES 21,
FES22, FES29 AND FES 61) (Figure 7E–F). Specific mark-
ers of all three germ layer derivatives (Figure 5E–G) were
detected from teratomas of all lines both with IHC (Table
1) and RT-PCR (Table 2). Vimentin-positive mesenchy-
mal tissues as well as desmin-positive muscle cells were
abundant signs of mesodermal differentiation. Likewise,
ectoderm-derived neurofilament-positive cells were fre-
quent in most tumors, although least in FES 30 teratomas
(Table 1). Definitive endodermal derivatives, character-
ized by gut-like mucoid epithelial structures with FoxA2/
HNF-3β-positive cells were relatively abundant in terato-
mas derived from particularly the FES 21 line, but only
rarely detected in FES 30-teratomas (Table 1). In RT-PCR
analyses teratomas from FES 30 were positive for ectoder-
mal and mesodermal marker genes but not for endoder-
mal genes. In contrast, teratomas from other analyzed FES
lines showed clear signals also for endodermal markers
(Table 2).
Discussion
We have successfully derived and expanded five hESC
lines characterized by previously established criteria,
including the capacity to differentiate both in vitro and in
vivo into derivatives of all three germ cell layers. However,
distinct line specific features were observed in terms of dif-
ferentiation patterns. One of the novel lines, FES 30,
repeatedly produced fewer, less diverse and smaller EBs
than the other lines. FES 30 cells also maintained the
expression of pluripotency-associated genes longer and
differentiated less readily than the other lines when
allowed to form embryoid bodies in vitro or teratomas in
vivo.
In our previous genetic profiling of the four FES lines [9]
the overall expression patterns were remarkably similar
and FES 30 cells did not differ from the others in any
major way. The expression levels of known pluripotency
factors OCT-4 and NANOG that might be involved in the
regulation of the differentiation tendency of hESC were
verified by qRT-PCR revealing fairly constant expression
Gene expression Figure 4
Gene expression. RT-PCR analysis of expression of typical 
genes associated with pluripotency in hESC, together with 
some primordial germ cell markers in undifferentiated hESCs 
(FES 22, 29 and 30), embryoid bodies (FEB22, 29 and 30), 
pooled stage 3 (ST3) differentiated cells and negative control 
(H2O).BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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of these genes in all cell lines. Yet, "functional tests" like
teratoma or EB formation indicate that prominent varia-
tion between the cell lines may exist. Parallel to our find-
ing, a recent study with mouse embryonic stem cell
(mESC) indicated that even monozygotic twin mESC
lines (i.e. two individual lines derived from a single ICM
by dissecting the ICM into two parts prior to establishing
the cell line) have differences in their differentiation pat-
terns, suggesting that individual cells/cell compartments
within the ICM may be committed to distinct develop-
mental pathways or that at the time of ESC line formation
the microenvironment may direct ESC line properties
[20]. Several other hypothetical reasons for variable differ-
entiation capacities can be postulated. For example some
lines may be more prone to general or regional epigenetic
changes occurring during culture and this might affect dif-
ferentiation properties of the hESC lines. Alternatively, the
embryos from which the lines are derived may have devel-
opmental defects that are not evident at blastocyst stage
but manifest only later. Interestingly, the FES 30 cell line
is the only female cell line used in our study. The role of
the gender is expected to be irrelevant in early develop-
mental processes but it can be hypothesized that for exam-
ple epigenetic processes could be differently controlled in
female and male lines which might also affect differentia-
tion potential of the hESC. Nevertheless, this finding
highlights the importance of conducting biological exper-
iments with more than one cell line before drawing gen-
eral conclusions about hESC physiology.
Analysis of EB formation Figure 6
Analysis of EB formation. Fifty hESC colonies were 
placed in suspension culture and the number of developing 
EBs counted after 2, 4 and 7 days. The FES 30 line formed 
fewer EBs already after 4 days as compared to FES 22 and 29 
(p < 0.01 at d 4 and < 0.001 at d 7, mean ± SD, n = 7).
Analysis of embryoid bodies (EBs) and teratomas Figure 5
Analysis of embryoid bodies (EBs) and teratomas. Specific markers of all three germ cell layer derivatives detected in 
EBs (A-D) and teratomas (E-G) from FES line 29. Phase contrast image of EB (A). Neuroectoderm differentiation is indicated 
by immunostaining for neurofilament (B, F); mesoderm differentiation by expression of brachyury (C) and desmin (E); endo-
derm differentiation by positivity for HNF3β (D, G). Original magnification 10× (A), 20× (B, C, E-G), 40× (D).BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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Cell-line dependent differentiation patterns Figure 7
Cell-line dependent differentiation patterns. Spontaneous differentiation is lower in 7-day EBs (A-D) and teratomas (E-F) 
derived from FES 30 cells (B, D, F) than FE2 22 cells (A, C, E). OCT-4 was detected by immostaining in EBs (A-B, dark brown 
color) and it remained much higher in FES 30 EBs. In contrast, brachyury expression, as a marker of mesodermal differentia-
tion, was clearly detectable in FES 22 (C) but was not detected in FES 30 EBs (D). Teratomas derived from FES 22 cells showed 
typical multi-lineage tissue differentiation (E) while a major part of FES 30 teratomas consisted of cystic structures (collapsed 
cyst wall shown in F). Original magnification 4×.BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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Three of the novel hESC lines were established on human
foreskin fibroblasts as reported by Hovatta et al [21] in
order to minimize the exposure of the cells to non-human
compounds. Only five hESC lines could be established
out of the 70 successful ICM isolations, which correspond
to a 7% success rate. In our IVF clinic the respective
implantation rate (= fetuses/transferred embryos) for
blastocysts derived from frozen-thawed embryos is over
30%, indicating that the quality of the embryos should
probably allow a substantially higher success rate for
hESC line establishment. Based on our experience, HFFs
do not support hESC growth as well as MEFs. However, it
has been shown [22] that there is substantial variation
between different human feeder types in their capacity to
support the self-renewal of hESCs. It is possible that
another human feeder cell type could support hESC
growth and self-renewal better than our current HFFs. This
may also have affected the derivation efficacy of new hESC
lines.
All the FES lines have been in continuous culture for one
to three years (50–120 passages) without losing their
pluripotency. Normal 46 XX (FES 30) or XY (FES 21, 29,
30 and 61) karyotypes have been detected at least twice
for every FES line, mainly on HFF feeders. However, after
transferring the cells on MEF feeders and starting to pas-
sage them enzymatically, changes in the chromosomal
constitutions of FES 22 and 30 involving chromosomes
12, 17 and 20 were found. Similar kinds of changes
(recurrent gain of chrs 17q and 12) have been reported for
three other hESC lines [23]. Cowan et al [24] reported the
derivation of 17 new hESC cell lines that were passaged by
trypsin from the beginning. General chromosomal
changes (trisomy, additions to chr 2) were observed in
these lines after prolonged culture. One possible explana-
tion for this may be linked to the passaging method. Enzy-
matic trypsin- or collagenase-based methods most likely
favor the selection of fast growing cells, which may have
undergone mutations or chromosomal rearrangements.
We propose that mechanical splitting methods should be
used initially for the first 20–30 passages to ensure that
karyotypically normal frozen stocks can be established.
These findings also emphasize the importance of frequent
karyotype analyses to assure that results obtained in any
studies with hESCs are not biased because of abnormal
chromosomal constitution.
To identify new specific markers for hESC cells and to
reveal genes possibly involved in the maintenance of
pluripotency, we analyzed the mRNA expression of sev-
Table 2: Gene expression in teratomas of FES lines 22, 29, 30 and 61.
Germ layer Marker gene FES 22 FES29 FES61 FES30
Mesoderm (muscle) C-ACTIN + +++
Mesoderm (muscle) MYOSIN + +++
Mesoderm (bone) CMP + +++
Ectoderm (neuron) NEUROFILAMENT L ++ +-
Ectoderm (neuron) TUBULIN 3β + +++
Endoderm FOXA2 (HNF-3β)+ + + -
Endoderm HNF1a ++ +-
Endoderm HNF1b ++ +-
Endoderm HNF6 ++ +-
Endoderm (liver) ALBUMIN ++ +-
Endoderm (pancreas) PDX-1 ++ +-
ES cell OCT-4 - ---
Table 1: Analysis of 16 mouse intratesticular teratomas derived from the five FES lines
Structure Antigen FES 21 FES 22 FES 29 FES 30 FES 61
n = 3 n = 4 n = 4 n = 4 n = 1
Mesenchyme (Mesoderm) Vimentin ++++ ++++ +++ +++ ++++
Muscle (Mesoderm) Desmin +++ +++ + + ++
E p i t h e l i u m C K - 1 9 + + + + ++ ++ ++ +
Neuron (Ectoderm) Neurofilament ++ ++ ++ + ++
Endoderm HNF-3β ++ + + +/- ++
Cell proliferation Ki-67 ++ ++ ++ + ++
Gut-like structures +++ +++ ++ +/- +++
Cystic tumor - - +/- ++ -BMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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eral germ cell associated genes at various stages of hESC
differentiation. The fact that hESCs (and mESCs) express
several markers that distinguish epiblast cells from early
PGCs as well as some other findings related to the forma-
tion of mESC lines have raised the question whether ES
cells might actually be more closely related to PGCs than
epiblastic cells [19]. Stella (also known as Dppa3 or Pgc7)
is a transcription factor exclusively expressed in a subset of
mouse epiblastic cells committed to become primordial
germ cells [25]. DAZL is an autosomal homologue of the
Y-chromosomal DAZ gene and is expressed in humans
also in oocytes and preimplantation embryos up to blast-
ocyst stage [26]. Recently, DAZ and DAZL were shown to
interact with PUM2 protein [27] which is a homologue to
Drosophila pumilio, an essential gene in maintaining the
normal primordial germ cell population of the adult fly
[28]. According to our expression analyses, these genes, as
well as testes specific PIWIL2 and TEX-14 [29,30], can be
used as markers for undifferentiated hESCs. The exact bio-
logical roles or interactions with other genes of any of
these PGC/germ cell associated genes are not known.
However, our results indicate that hESCs express several
germ cell associated genes that may be involved in the
molecular mechanisms regulating early differentiation
and/or self-renewal of these cells.
Conclusion
We have derived five new hESC lines and characterized
them extensively. Several important lessons can be
learned from this work: First, due to poorly understood
reasons, the lines may vary substantially in their sponta-
neous differentiation properties even though there are no
obvious differences in the generally accepted ES cell char-
acteristics in the undifferentiated state. Second, in order to
obtain a cell growth rate required for many purposes, the
hESCs need to be grown on embryonic mouse feeders
which also make it possible to use enzymatic instead of
mechanical passaging of the cells. However, these condi-
tions may of the lead to chromosomal instability. Third,
several genes expressed in primordial germ cells may serve
as useful additional pluripotency markers.
Methods
Derivation of hESCs
In vitro fertilized excess human embryos were donated for
the generation of hESC lines after an informed consent of
the respective couples. The Ethical Committee of the Hos-
pital district of Helsinki and Uusimaa has approved the
generation of hESC lines. The embryos frozen at day 2
were thawed and cultured up to blastocysts. The ICMs of
day 5 or 6 blastocysts were isolated by first degrading zona
pelluzida using 0.5% Pronase (Sigma-Aldrich/YA-Kemia,
Helsinki, Finland). For the lines FES 21, 22, 29 and 30, the
trophectoderm was removed by immunosurgery using
rabbit anti-human serum (Sigma-Aldrich) and guinea pig
serum complement (Sigma-Aldrich). For FES 61 the tro-
phectoderm was removed mechanically by needles. The
hESC lines FES 21 and FES 22 were initially derived and
cultured on mouse embryonic fibroblast feeders (MEF;
1213 pc fetuses of the ICR strain) and FES 29, 30 and 61
cell lines on human foreskin fibroblasts feeder cells (HFF;
CRL-2429 ATCC, Mananas, USA). FES 21 and 22 were cul-
tured on MEF for 10 and 28 passages, respectively. There-
after they were transferred on HFF.
Culture of hESCs (stage1)
The ICMs and hESCs were cultured either on HFF or MEF
feeders (mitotically inactivated by Mitomycin-C, density
27 000 cells/cm2 and 10 000 cells/cm2, respectively) in
serum-free medium (KnockoutD-MEM; Invitrogen, Pais-
ley, UK) supplemented with 2 mM L-Glutamin/Penicillin
streptomycin (Sigma-Aldrich), 20% Knockout Serum
Replacement (Gibco), 1 X non-essential amino acids
(Gibco), 0.1 mM betamercaptoethanol (Gibco), 1 X ITS
(Sigma-Aldrich) and 4 ng/ml recombinant bFGF (Invitro-
gen). The first splitting after ICM isolation was done after
10–14 days by mechanical disaggregation. The growing
cell aggregates were then passaged to new plates at 5–7
day intervals. HESCs cultured on HFFs were passaged
mechanically while those cultured on MEFs were passaged
either mechanically or enzymatically. For mechanical pas-
saging the colonies (which approximately contained 2000
cells) were cut into 4–5 pieces, and transferred on new
dishes (20–30 pieces/dish). For enzymatic passaging the
cells were exposed to 200 units/ml collagenase IV (Gibco)
for 5–10 min at 37°C, dissociated by gently pipetting and
plated on 2–3 new dishes.
Population doubling time
Depending on the experiment, 10 000 to 40 000 enzymat-
ically passaged hESCs that had been cultured on MEFs
were plated on 24-well tissue culture plates pre-seeded
either with MEF or HFF feeder cells. After two days, three
wells with MEF and HFF feeders without hESCs were
trypsinized and counted to give the average number of
feeders per well. Also, three wells of hESCs on both feed-
ers were trypsinized and counted to give the reference
number of hESCs per well. Thereafter, at time points 24
and 48 hours three wells with hESCs on both feeders were
harvested and cell numbers were counted. The feeders
were subtracted from total cell counts and the population
doubling times of the hESCs calculated on both feeder
types.
Karyotyping
For karyotype analysis the hESCs cultured on HFF feeders
were first transferred on feeder free culture for approxi-
mately 2 weeks. The cells were then harvested by trypsini-
zation and metaphases were analyzed using conventional
light microscope (Olympus, BX 50) and karyotypes wereBMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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made using IKAROS-software designed for chromosome
analysis (MetaSystems GmbH, Altlussheim, Germany).
20 metaphases were analysed for each cell line. Alterna-
tively, cells grown on MEF feeders were treated directly
with colchisine for two hours and then harvested and
metaphases were analyzed.
RNA isolation, RT-PCR and immunohistochemistry (IHC)
Total RNA was isolated from hESCs, EBs and cells grown
out of the EBs (stage 3 differentiated cells) by SV Total
RNA system (Promega, Madison, WI, USA). Total RNA
from teratomas was isolated by NucleoSpin RNA II kit
(Macherey-Nagel, Germany). Two μg of total RNA treated
with RQ1 RNase-Free DNase (Promega,) was used for 20
μl of reverse transcription reaction with M-MLV Reverse
Transcriptase (Promega). Nucleotides were purchased
from Roche Applied Science (Penzberg, Germany) and
oligo (dT)15 Primers from Promega. One μl of each RT
reaction was used for PCR amplification with AmpliTaq
Gold DNA polymerase (Applied Biosystems, CA, USA).
Primer pairs used are listed in Table 3.
Undifferentiated ES cell colonies were fixed in the culture
dishes by 4% PFA for the immunocytochemical detection
of the stem cell surface markers, SSEA-4, Tra 1–60 and Tra
1–81 (in dilutions 1:100). Primary antibodies were
obtained from the Developmental Studies Hybridoma
Bank (Iowa City, IA, USA; SSEA-4 and Tra 1–60) and
Chemicon International (Temecula, CA, USA; Tra 1–81).
The same antibody (SSEA-4) was used for flow cytometric
analysis (FACSCalibur, Becton Dickinson, NJ, USA).
Immunohistochemical studies of teratomas and EBs were
done in paraffin sections. The rehydrated sections were
microwave treated in 1 mM EDTA, pH 8, for 15 minutes
to reveal antigenic sites, cooled at room temperature (RT)
for 30 minutes and rinsed in aqua. Endogenous peroxi-
dase was inactivated with 3% hydrogen peroxide in aqua
for 10 minutes. After rinsing with PBS the sections were
incubated in 4% normal goat or rabbit serum (Vector Lab-
oratories, Burlingame, CA, USA) in PBS-0.1% Tween20
for 2 hours at RT to block nonspecific binding sites. Pri-
mary antibodies (mouse anti-vimentin and mouse anti-
cytokeratin-19, DakoCytomation, Glostrup, Denmark;
goat anti-human brachyury, rabbit anti-desmin and goat
anti-HNF3β Santa Cruz Biotechnology, Santa Cruz, CA,
USA; monoclonal mouse anti-neurofilament high anti-
body 13A8, a gift from Prof. Ismo Virtanen, University of
Helsinki, Helsinki, Finland, Ki-67, Novocastra, Newcastle,
UK) were diluted (1:5000, 1:500, 1:200, 1:3000, 1:5000
and 1:1000, respectively) in PBS containing 4% normal
serum and Tween-20 and incubated overnight at +4 C.
After rinsing several times with PBS, the sections were
incubated with biotinylated goat anti-rabbit, rabbit anti-
mouse or rabbit anti-goat secondary antibody (Zymed
Laboratories, San Francisco, CA, USA) in PBS-Tween for
30 minutes at RT, rinsed in PBS and incubated with per-
oxidase conjugated streptavidin (Zymed Laboratories)
diluted in PBS-Tween. The sections were finally developed
with AEC substrate (3-amino-9-ethyl carbazole; Lab
Vision Corporation, Fremont, CA, USA). After rinsing
with water counterstaining was performed with Mayer's
hemalum solution. Alkaline phosphatase activity in the
hESC lines was demonstrated by a commercial kit
(Chemicon).
Table 3: PCR primers used.
Name GenBank Sequence of 5'-primer Sequence of 3'-primer Product size
DAZL NM_001351 GGAGCTATGTTGTACCTCC CCATGTAACTAGATAAGCCAG 313 bp
PIWIL2 BC025995 TCTATGGGGCCATCAAGAAG CCATCCCGATCACCATTAAC 195 bp
TEX14 BK000998 TCCTGTTTTTGGAAGCGACT GTGGCAGCTGAACAAAGTGA 214 bp
STELLA AY317075 CACAAATGCTCACCGAAGAA TTCGATTTCCCTGAGGACTG 182 bp
FGF4 NM_002007 TCACCGATGAGTGCACGTTCA GAGGAAGTGGGTGACCTTCAT 158 bp
NANOG AB093576 GGAAGACAAGGTCCCAGTCA ATTGTTCCAGGTCTGGTTGC 349 bp
OCT4 XM_084899 CGTGAAGCTGGAGAAGGAGAAGCTG AAGGGCCGCAGCTTACACATGTTC 245 bp
PUM2 AF315591 CCAACATTCCTTGGTGAG ATCAGGACCCCAAGAAGAGG 402 bp
C-ACTIN NM_005159 TGATATCCGCAAGGACCTGT GCTGGAAGGTGGACAGAGAG 200 bp
MYOSIN NM_013292 TCCATGTTCGACCAGACTCA AAGCGGTCACACTGCGTGGT 335 bp
CMP NM_002379 AGAGCTACAGCGTCATCGAG TCTGACACGTCCAGCGTATC 316 bp
NF-L NM_006158 CAAAGAGTGAAATGGCACGA AGCGGGTGGACATCAGATAG 231 bp
TUBULIN3β NM_006086 CATCCAGAGCAAGAACAGCA TCGGTGAACTCCATCTCGTC 234 bp
ALBUMIN XM_031320 GCACAATGAAGTGGGTAACC CAGCAGTCAGCCATTTCACC 349 bp
FOXA2 NM_021784 TGCCAGGAGCACAAGCGAGG TGTTCGTAGGCCTTGAGGTCC 290 bp
HNF1α NM_000545 CAGGTCTTCACCTCAGACAC GAGGCCATCTGGGTGGAGAT 263 bp
HNF1β NM_000458 ACCTTGACGAATATCCACAGC CTGTGACCACCATTGCAGATG 364 bp
HNF6 U96173 AGGGCAGATGGAAGAGATCA TGGATGGACGCTTATTTTCC 377 bp
PDX1 U30329 ACCAAAGCTCACGCGTGGAA CTCTCGGTCAAGTTCAACAT 191 bp
GAPDH M33197 GTCTTCACCACCATGGAGAAGGCT TGTAGCCCAGGATGCCCTTGAGGG 529 bpBMC Developmental Biology 2006, 6:40 http://www.biomedcentral.com/1471-213X/6/40
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Embryoid body (stage 2) differentiation
To induce the formation of embryoid bodies (EBs) the
hESC colonies were first allowed to grow for 10–14 days.
Thereafter the colonies were cut in small pieces (approxi-
mately 5000 cells) and transferred on non-adherent Petri
dishes (Becton Dickinson, NJ, USA) to form suspension
cultures. The hESCs were then cultured for the next 10
days in suspension in standard culture medium (see
above) without bFGF. The formed EBs were either fixed
with 4% PFA and subjected to IHC analyses or used for
total RNA isolation and RT-PCR analyses.
For the comparison of the EB formation efficacy, the
hESCs on MEF feeders were treated with collagenase IV (1
mg/ml) for one hour. The floating colonies were then
transferred to non-adherent Petri dishes, 50 colonies in
each well (Becton Dickinson, NJ, USA). The experiments
were repeated 7–8 times depending on cell line. After 7
days in standard culture medium the EBs were counted
and fixed with 4% PFA for immunohistochemical analysis
and morphometry by Image-Pro Plus 4.5 software (Media
Cybernetics Inc.). Statistical significance of the observed
differences was tested by unpaired Student's t test.
Stage 3 differentiation
To induce further differentiation, embryoid bodies were
transferred onto gelatin-coated (Sigma-Aldrich) adherent
culture dishes in DMEM/F12 media (Gibco) supple-
mented with ITS, Fibronectin (Sigma), L-glutamine and
antibiotics. The attached cells were grown for 10 days,
whereafter they were harvested and total RNA was iso-
lated.
Teratoma formation
In order to study teratoma formation, about 200 000 mor-
phologically good looking hESC cells were injected into
nude mice testes. The resulting tumors were harvested at 8
weeks after injection. A part of the tumor was used for
RNA isolation and the remaining part fixed with 10% for-
malin and immunohistologically examined. The animal
experiments were approved by the experimental animal
welfare committee of the District Government of South-
ern Finland.
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